Skip to main content
DXCM logo

DexCom, Inc.

DXCMNASDAQHealthcareMedical Devices

$86.04Today:- (-)1Y +31.70%

As of Oct 16, 2026 close

Market cap
$34.22B
P/E (TTM)
34.23
Forward P/E
19.94
Dividend yield
-
52-week range
$54.11$92.59
Volume (live)
-
Avg. volume (3M)
3.95M

DexCom (DXCM) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), DexCom reported total assets of $6.34B and total liabilities of $3.59B. Shareholders' equity was $2.75B, up 30.6% from $2.10B a year earlier. Total debt stood at $1.26B against $2.00B in cash and short-term investments, a net cash position of $736.20M. That puts debt-to-equity at 0.46, compared with 1.23 a year earlier.

DexCom Balance Sheet Analysis

Values in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for DexCom, Inc. (DXCM) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents0.920.610.570.641.050.820.451.140.44
Short-Term Investments1.081.972.161.811.681.891.090.250.11
Cash & Short-Term Investments2.002.582.722.462.732.711.531.390.55
Accounts Receivable1.221.030.990.710.520.430.290.230.13
Inventory0.630.540.560.370.360.230.120.070.05
Other Current Assets0.030.150.150.190.080.050.030.020.02
Total Current Assets4.034.304.433.673.683.421.971.700.74
Non-Current Assets
Property, Plant & Equipment (Net)1.641.401.181.140.890.610.390.180.15
Long-Term Investments0.220.120.040.020.000.000.000.000.00
Goodwill0.020.020.030.030.030.020.020.020.01
Intangible Assets0.070.100.130.170.030.020.000.000.00
Other Non-Current Assets0.040.050.040.390.010.000.010.010.00
Total Non-Current Assets2.312.181.841.721.250.870.430.220.16
Total Assets6.346.486.265.394.934.292.401.920.90
Current Liabilities
Accounts Payable0.340.350.280.900.190.160.100.080.05
Short-Term Debt0.021.230.020.770.020.020.010.000.00
Current Portion of Long-Term Debt-1.20-0.77-----
Accrued Liabilities1.681.251.140.130.13----
Deferred Revenue0.010.010.020.010.000.000.000.000.00
Other Current Liabilities0.011.311.190.010.470.420.230.130.08
Total Current Liabilities2.142.931.561.840.720.610.360.220.14
Non-Current Liabilities
Long-Term Debt1.241.362.571.202.141.821.151.020.33
Deferred Tax Liabilities0.000.000.000.000.010.000.000.000.00
Other Non-Current Liabilities0.020.080.060.130.010.030.010.010.01
Total Non-Current Liabilities1.451.452.641.422.171.851.151.030.35
Total Liabilities3.594.384.203.262.892.461.511.250.48
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.000.000.00
Retained Earnings2.431.601.020.480.14-0.20-0.70-0.80-0.67
Accumulated Other Comprehensive Income0.12-0.01-0.02-0.010.000.000.000.000.00
Treasury Stock2.081.582.450.60-----
Additional Paid-in Capital2.280.511.061.661.902.031.581.461.09
Shares Outstanding0.380.390.390.39-----
Total Stockholders' Equity2.752.102.072.132.041.830.880.660.42
Total Liabilities & Equity6.346.486.265.394.934.292.401.920.90

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About DexCom Balance Sheet

How much debt does DexCom have?

DexCom had total debt of $1.26B as of Dec 31, 2025, against $2.00B in cash and short-term investments. Its debt-to-equity ratio was 0.46. Total debt was $2.59B a year earlier.

What are DexCom's total assets?

DexCom reported total assets of $6.34B as of Dec 31, 2025, down 2.2% from $6.48B a year earlier. Total liabilities were $3.59B.

What is DexCom's shareholders' equity?

DexCom's shareholders' equity was $2.75B as of Dec 31, 2025, or about $7.14 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition